

Vertex Pharmaceuticals
"A global biotechnology company creating transformative medicines for serious diseases"
About Vertex Pharmaceuticals
Vertex Pharmaceuticals invests in scientific innovation to discover, develop, and produce medicines that transform lives for people with serious diseases. The company focuses on specialty markets, bringing together world-class talent, cutting-edge science, and calculated risk-taking to strike at the core of complex conditions. From cystic fibrosis to sickle cell disease, type 1 diabetes, and kidney diseases, Vertex channels most resources back into research and development. With headquarters in Boston and London, and global sites advancing cell therapies, gene editing, and non-opioid pain treatments, the company turns scientific possibility into medical breakthroughs.


6400
Team Members
1989
Founded
Public
Funding
Hybrid
Work Environment
A world where serious diseases no longer limit human potential, where scientific possibility becomes reality for every person waiting for a cure.
At Vertex, our mission is to create transformative medicines for people with serious diseases with a focus on specialty markets.